Individual risk assessment for prostate cancer: an impact analysis.

Completed

• Conditions: prostate cancer; Prostate carcinoma; 10038588; 10036958

• Registration Number: NL-OMON35373
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 650

Inclusion Criteria

* Men between 55 and 75 years old
* Confronted with the option of undergoing a diagnostic prostate biopsy or wanting to be screened for prostate cancer
* Signed informed consent

Exclusion Criteria

History of prostate cancer

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary endpoints are adherence, compliance and impact on the patient.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Alongside the implementation process, the data available on the number of<br /><br>biopsies and referral to active surveillance before and after implementation of<br /><br>the Prostaatwijzer ®, as well as costs, will be compared.</p><br>